Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
29%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
PPH
26
HOLDINGS
17%
ALSO IN OZEM
OZEM
20
HOLDINGS
22%
ALSO IN PPH
SECTOR DRIFT (PPH minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.7% | 15.6% | 15.6% |
 |
NOVO-NORDISK A/S-SPONS ADR | 6.1% | 19.8% | 6.1% |
|
PFIZER INC | 4.8% | 4.0% | 4.0% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.0% | 3.4% | 3.4% |
PPH Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 11.6% |
 |
NOVARTIS AG-ADR | 7.9% |
|
MERCK & CO. INC. | 6.4% |
|
ABBVIE INC | 5.0% |
 |
SANOFI-AVENTIS-ADR | 4.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.4% |
|
MCKESSON CORP | 4.4% |
|
BRISTOL-MYERS SQUIBB CO | 4.4% |
|
ZOETIS INC | 4.3% |
|
CENCORA INC | 3.7% |
PPH Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -13.6% |
|
ZEALAND PHARMA A/S | -6.4% |
|
ROCHE HOLDING LTD | -5.3% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.5% |
 |
INNOVENT BIOLOGICS, INC. | -4.4% |
|
AMGEN INC | -3.3% |
 |
HANMI PHARM CO LTD | -3.0% |
|
VIKING THERAPEUTICS, INC. | -2.9% |
|
TERNS PHARMACEUTICALS, INC. | -2.8% |
|
REGENERON PHARMACEUTICALS | -2.5% |